Table 1.
TCGA patient samples analysed in this study.
| cancer type | TCGA abbreviations | number of samples | number of participants |
|---|---|---|---|
| breast invasive carcinoma | BRCA | 220 | 110 |
| kidney renal clear cell carcinoma | KIRC | 144 | 72 |
| thyroid carcinoma | THCA | 116 | 58 |
| lung adenocarcinoma | LUAD | 114 | 57 |
| prostate adenocarcinoma | PRAD | 104 | 52 |
| liver hepatocellular carcinoma | LIHC | 100 | 50 |
| lung squamous cell carcinoma | LUSC | 98 | 49 |
| head and neck squamous cell carcinoma | HNSC | 84 | 42 |
| kidney renal papillary cell carcinoma | KIRP | 62 | 31 |
| stomach adenocarcinoma | STAD | 54 | 27 |
| colon adenocarcinoma | COAD | 48 | 24 |
| kidney chromophobe | KICH | 46 | 23 |
| bladder urothelial carcinoma | BLCA | 38 | 19 |